Mojirade James's Net Worth
$697 Thousand
Who is Mojirade James?
Mojirade James does not have any significant net worth to report based on the numbers we have. This is based on reported shares in AVANOS MEDICAL, INC..
SEC CIK
Mojirade James's CIK is 0001872825
Past Insider Trading and Trends
2021 was Mojirade James's most active year for acquiring shares with 1 total transactions. Mojirade James's most active month to acquire stocks was the month of February. 2023 was Mojirade James's most active year for disposing of shares, totalling 2 transactions. Mojirade James's most active month to dispose stocks was the month of June. 2021 saw Mojirade James paying a total of $250,006.68 for 7,308 shares, this is the most they've acquired in one year. In 2023 Mojirade James cashed out on 2,774 shares for a total of $79,865.27, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AVANOS MEDICAL, INC. (AVNS) Snapshot price: $19.1
SVP, General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.96% | -684.00 |
$21.99 | -$15,041.16 | 70.31K |
Jul 22
| |||
Form 4
| +68.03% | 28.74K |
$19.07 | $550,433.30 | 71K |
Mar 6
| |||
Form 4
| -4.93% | -2.19K |
$18.76 | -$41,084.40 | 42.25K |
Mar 5
| |||
Form 4
| -1.47% | -663.00 |
$26.15 | -$17,337.45 | 44.44K |
Jul 20
| |||
Form 4
| +67.82% | 18.23K |
$29.62 | -$62,527.82 | 45.11K |
Mar 6
| |||
Form 4
| -2.41% | -663.00 |
$27.41 | -$18,172.83 | 26.88K |
Jul 20
| |||
Form 4
| +276.86% | 20.23K |
—
|
—
| 27.54K |
Mar 4
| |||
Form 4
|
∞
| 7.31K |
$34.21 | $250,006.68 | 7.31K |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||